Longevous Beamtech Co., Ltd.

About Longevous Beamtech Co., Ltd.

A Other / Uncategorized player with a presence on the SNMMI floor; commercial activity worth a closer look.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• BioPharma Reporter · 2026-02-27
  Longevous Beamtech Co Ltd publishes dosimetry data at SNMMI 2026
  Coverage notes the company's growing footprint in the radioligand therapy space.
• FierceBiotech · 2026-05-24
  Longevous Beamtech Co Ltd closes Series C round to scale radiopharma manufacturing
  The work builds on more than a decade of radiochemistry collaboration.
• Endpoints News · 2026-08-17
  Longevous Beamtech Co Ltd partners with academic center on Actinium-225 program
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Reuters Health · 2026-11-10
  Longevous Beamtech Co Ltd files IND for next-generation PSMA-targeted agent
  The announcement comes amid tightening Mo-99 and Lu-177 supply.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.